We are pleased to welcome Dieter Weinand and Carsten Reinhardt to our Board of Directors, as Chairman and Independent Director, respectively.
Welcome to the team!
We are excited to have you both on board.
https://t.co/DQOSX4ty37
#surfaceome#drugdiscovery#biotech
Our website is live.
Meet the team and read more about what we do and how we will transform the landscape of cancer care.
Keep up to date with what's happening at DISCO by following us at @DISCO Pharmaceuticals on LinkedIn and @DISCOPharma on #X
https://t.co/DQOSX4ty37
Introducing @DISCOPharma!
The #surfaceome company.
DISCO's mission is to improve treatment options for patients living with cancer by unleashing the full potential of targeted cancer therapies.
Find out more: https://t.co/cWHtBFL0ff
#drugdiscovery#biotech
>$600M in capital raised.
16 programs.
10 companies.
4 months from Series A to IPO.
All coming together to form 1 amazing team.
Congratulations Centessa!
#NasdaqListed @centessa is a new kind of pharmaceutical company delivering asset centricity at scale. 🎉😍👏
Today, the $CNTA team rang the @Nasdaq Closing Bell in honor of their recent IPO. Congratulations!🛎️